Does ocular treatment of uveal melanoma influence survival

British Journal of Cancer

Volumn 103, Issue 3, 2010, Pages 285-290

  Damato, B ^a  

^a ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

clinical trials; oncology; research; surgery; uveal melanoma

Indexed keywords

BRACHYTHERAPY; CANCER SURVIVAL; CLINICAL PRACTICE; GENETIC DISORDER; HUMAN; METASTASIS; MORBIDITY; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; SHORT SURVEY; TRANSPUPILLARY THERMOTHERAPY; UVEA MELANOMA;

CHOROID NEOPLASMS; COMBINED MODALITY THERAPY; EYE ENUCLEATION; HUMANS; MELANOMA; NEOPLASM METASTASIS; PROGNOSIS; RADIOTHERAPY; SURVIVAL RATE; UVEAL NEOPLASMS;

EID: 77955041701     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6605765     Document Type: Short Survey

References (30)

1. Augsburger JJ, Correa ZM, Shaikh AH (2009) Effectiveness of treatments for metastatic uveal melanoma. Am J Ophthalmol 148: 119-127
2. Augsburger JJ, Correa ZM, Trichopoulos N (2007) An alternative hypothesis for observed mortality rates due to metastasis after treatment of choroidal melanomas of different sizes. Trans Am Ophthalmol Soc 105: 54-59; discussion 59-60
3. Bechrakis NE, Höcht S, Martus P, Kreusel KM, Heese J, Foerster MH (2004) Endoresection following proton beam irradiation of large uveal melanomas. Ophthalmologe 101: 370-376
4. Bove R, Char DH (2004) Nondiagnosed uveal melanomas. Ophthalmology 111: 554-557
5. Collaborative Ocular Melanoma Study Group (2006) The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: V. Twelve-year mortality rates and prognostic factors: COMS report no. 28. Arch Ophthalmol. 124. 1684-1693
6. Damato B (2001) Detection of uveal melanoma by optometrists in the United Kingdom. Ophthalmic Physiol Opt 21: 268-271 (Pubitemid 32433354)
7. Damato B (2006) Treatment of primary intraocular melanoma. Expert Rev Anticancer Ther 6: 493-506
8. Damato B, Coupland SE (2009) A reappraisal of the significance of largest basal diameter of posterior uveal melanoma. Eye 23: 2152-2160
9. Damato B, Dopierala J, Klaasen A, van Dijk MC, Sibbring JS, Coupland SE (2009) Multiplex ligation-dependent probe amplification of uveal melanoma: correlation with metastatic death. Invest Ophthalmol Vis Sci 50(7): 3048-3055
10. Damato B, Duke C, Coupland SE, Hiscott P, Smith PA, Campbell I, Douglas A, Howard P (2007) Cytogenetics of uveal melanoma: a 7-year clinical experience. Ophthalmology 114: 1925-1931
11. Damato B, Eleuteri A, Fisher AC, Coupland SE, Taktak AF (2008) Artificial neural networks estimating survival probability after treatment of choroidal melanoma. Ophthalmology 115: 1598-1607
12. Damato B, Lecuona K (2004) Conservation of eyes with choroidal melanoma by a multimodality approach to treatment: an audit of 1632 patients. Ophthalmology 111: 977-983
13. Desjardins L, Dorval T, Lévy C, Cojean I, Schlienger P, Salmon RJ, Validire P, Asselain B (1998) Randomised study on adjuvant therapy by DTIC in choroidal melanoma. Ophtalmologie 12: 168-173
14. Dopierala J, Damato BE, Lake SL, Taktak AF, Coupland SE (2010) Genetic heterogeneity in uveal melanoma assessed by multiplex ligation-dependent probe amplification. Invest Ophthalmol Vis Sci, e-pub ahead of print 19 may 2010; doi:10.1167/10rs.09-5004
15. Ehlers JP, Worley L, Onken MD, Harbour JW (2008) Integrative genomic analysis of aneuploidy in uveal melanoma. Clin Cancer Res 14: 115-122
16. Eskelin S, Kivelä T (2002) Mode of presentation and time to treatment of uveal melanoma in Finland. Br J Ophthalmol 86: 333-338
17. Eskelin S, Pyrhönen S, Hahka-Kemppinen M, Tuomaala S, Kivelä T (2003) A prognostic model and staging for metastatic uveal melanoma. Cancer 97: 465-475
18. Eskelin S, Pyrhönen S, Summanen P, Hahka-Kemppinen M, Kivelä T (2000) Tumor doubling times in metastatic malignant melanoma of the uvea: tumor progression before and after treatment. Ophthalmology 107: 1443-1449
19. Gragoudas ES, Lane AM, Munzenrider J, Egan KM, Li W (2002) Long-term risk of local failure after proton therapy for choroidal/ciliary body melanoma. Trans Am Ophthalmol Soc 100: 43-48; discussion 48-49
20. Hawkins BS (2004) The Collaborative Ocular Melanoma Study (COMS) randomized trial of pre-enucleation radiation of large choroidal melanoma: IV. Ten-year mortality findings and prognostic factors. COMS report number 24. Am J Ophthalmol 138: 936-951
21. Kujala E, Makitie T, Kivela T (2003) Very long-term prognosis of patients with malignant uveal melanoma. Invest Ophthalmol Vis Sci 44: 4651-4659
22. Manschot WA, van Strik R (1987) Is irradiation a justifiable treatment of choroidal melanoma? Analysis of published results. Br J Ophthalmol 71: 348-352
23. Onken MD, Worley LA, Ehlers JP, Harbour JW (2004) Gene expression profiling in uveal melanoma reveals two molecular classes and predicts metastatic death. Cancer Res 64: 7205-7209
24. Parrella P, Sidransky D, Merbs SL (1999) Allelotype of posterior uveal melanoma: implications for a bifurcated tumor progression pathway. Cancer Res 59: 3032-3037
25. Prescher G, Bornfeld N, Hirche H, Horsthemke B, Jöckel KH, Becher R (1996) Prognostic implications of monosomy 3 in uveal melanoma. Lancet 347: 1222-1225
26. Straatsma BR, Diener-West M, Caldwell R, Engstrom RE (2003) Mortality after deferral of treatment or no treatment for choroidal melanoma. Am J Ophthalmol 136: 47-54
27. Tschentscher F, Hüsing J, Hölter T, Kruse E, Dresen IG, Jöckel KH, Anastassiou G, Schilling H, Bornfeld N, Horsthemke B, Lohmann DR, Zeschnigk M (2003) Tumor classification based on gene expression profiling shows that uveal melanomas with and without monosomy 3 represent two distinct entities. Cancer Res 63: 2578-2584
28. Voelter V, Schalenbourg A, Pampallona S, Peters S, Halkic N, Denys A, Goitein G, Zografos L, Leyvraz S (2008) Adjuvant intra-arterial hepatic fotemustine for high-risk uveal melanoma patients. Melanoma Res 18: 220-224
29. White VA, Chambers JD, Courtright PD, Chang WY, Horsman DE (1998) Correlation of cytogenetic abnormalities with the outcome of patients with uveal melanoma. Cancer 83: 354-359
30. Zimmerman LE, McLean IW, Foster WD (1978) Does enucleation of the eye containing a malignant melanoma prevent or accelerate the dissemination of tumour cells. Br J Ophthalmol 62: 420-425